Breaking News

Enphase Energy should be bought on any weakness, says Roth Capital. Roth Capital analyst Philip Shen raised his price target for Enphase Energy to $6 from $5.50 after meeting with management. As the company aggressively drives out costs, the analyst expects it to regain share as it rolls out its unique and differentiated IQ7/IQ7x/IQ8 technology. Shen reiterates a Buy rating on the stock.

Solar 'doges bullet' as inverters/cells/modules sidestep 301 tariffs, says Roth Capital. Roth Capital analyst Philip Shen notes that inverters, solar cells, and solar modules were not on the 301 product list released on the USTR website providing which Chinese imports will be subject to 25% tariffs. A 301 tariff that increases module or inverter costs in the U.S. could have served as another dampener of U.S. solar demand, he contends, adding that the lack of impact represents an overall positive for the industry and positive for most in his coverage universe, including Canadian Solar (CSIQ), Enphase Energy (ENPH), First Solar (FSLR), Hanwah Q CELLS (HQCL), JinkoSolar (JKS), Sunrun (RUN), SolarEdge (SEDG), ReneSola (SOL), Sunworks (SUNW), and Yingli Green Energy (YGE).

Enphase should be bought on weakness as 301 tariffs do not apply, says Roth Capital. Roth Capital analyst Philip Shen notes that Enphase Energy sold off as much as 16% intraday due in part to the misunderstanding of a standard procedure. The analyst points out that the 301 product list subjected to 25% tariffs does not include inverters or Enphase, which had become a source of concern of him and some investors. Additionally, Shen notes that in the company's recent 2017 10K, Enphase shed its going concern risk factor, which he sees as a meaningful positive. The analyst would be a buyer as he continues to see upside for the stock. He reiterates a Buy rating and $5.50 price target on the shares.